Suprachoroidal Gene Therapy for Neovascular AMD
Phase I results of suprachoroidal delivery of a gene vector in treating neovascular AMD are promising. A discussion with Nikolas London, MD from Retina Consultant Group in San Diego CA & Scripps Memorial Hospital La Jolla.
Retina Synthesis
en-usFebruary 17, 2022